Travere Therapeutics Inc (TVTX) — Cash Flow Quality Index

Latest as of September 2025: 0.56x

Travere Therapeutics Inc (TVTX) has a Cash Flow Quality Index of 0.56x as of September 2025. Operating cash flow of $14.32 Million is below net income of $25.71 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore TVTX operating cash flow to assess how effectively this company generates cash.

Cash Flow Quality Index

0.56x
Operating CF / Net Income

Operating Cash Flow

$14.32 Million
USD

Net Income

$25.71 Million
USD

Data as of

Sep 2025
Most recent filing

Travere Therapeutics Inc Cash Flow Quality Index (2015–2015)

Historical Cash Flow Quality Index for Travere Therapeutics Inc across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check TVTX capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.

Annual Cash Flow Quality Index for Travere Therapeutics Inc (2015–2015)

Year-by-year earnings quality comparison for Travere Therapeutics Inc. For live market cap and the full company financial profile, see Travere Therapeutics Inc (TVTX) total market value.

Year Quality Index Operating CF (USD) Net Income YoY Change
2015 0.00x $-554.00K $117.24 Million
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.